Stina Singel
Chief Tech/Sci/R&D Officer at ASCENDIS PHARMA A/S
Net worth: 412 543 $ as of 2024-03-30
Profile
Stina Singel's career history includes current and former positions as well as education.
Currently, Dr. Singel is the Executive VP & Head-Clinical Development at Ascendis Pharma A.
Previously, Dr. Singel worked as the Senior Medical Director at Genentech, Inc. from 2014 to 2019 and as the SVP, Head-Clinical Development & Drug Safety at Nektar Therapeutics from 2019 to 2020.
Dr. Singel holds a doctorate degree from The Salk Institute for Biological Studies and the University of California San Diego, as well as an undergraduate degree from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0.01% | 2023-12-30 | 2,729 ( 0.01% ) | 412 543 $ | 2024-03-30 |
Stina Singel active positions
| Companies | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Tech/Sci/R&D Officer | 2020-04-30 |
Former positions of Stina Singel
| Companies | Position | End |
|---|---|---|
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 2020-04-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2019-03-31 |
Training of Stina Singel
| The Salk Institute for Biological Studies | Doctorate Degree |
| Harvard University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Stina Singel
